blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2593433

EP2593433 - N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.10.2015
Database last updated on 12.12.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Pfizer Limited
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
[2013/21]
Inventor(s)01 / BELL, Andrew Simon
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
02 / BROWN, Alan Daniel
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
03 / LEWTHWAITE, Russell Andrew
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
04 / PEREZ PACHECO, Manuel
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
05 / RAWSON, David James
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
06 / STORER, Robert Ian
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
07 / SWAIN, Nigel Alan
Pfizer Global Research and Development
Ramsgate Road
Sandwich Kent CT13 9NJ / GB
 [2013/21]
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2013/21]
Application number, filing date11746621.906.07.2011
WO2011IB52998
Priority number, dateUS201161491540P31.05.2011         Original published format: US 201161491540 P
US20100363421P12.07.2010         Original published format: US 363421 P
[2013/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012007877
Date:19.01.2012
Language:EN
[2012/03]
Type: A2 Application without search report 
No.:EP2593433
Date:22.05.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 19.01.2012 takes the place of the publication of the European patent application.
[2013/21]
Type: B1 Patent specification 
No.:EP2593433
Date:26.11.2014
Language:EN
[2014/48]
Search report(s)International search report - published on:EP08.03.2012
ClassificationIPC:C07D213/64, A61K31/18, A61P25/04
[2014/31]
CPC:
C07C311/51 (EP,US); A61K31/444 (US); A61K31/18 (US);
A61K31/4164 (US); A61K31/4418 (US); A61K45/06 (US);
A61P25/04 (EP); A61P29/00 (EP); C07C311/13 (US);
C07D213/64 (EP,US); C07D213/65 (EP,US); C07D213/69 (EP,US);
C07D231/12 (EP,US); C07D233/64 (US); C07D239/26 (EP,US);
C07D239/42 (EP,US); C07D401/12 (EP,US) (-)
Former IPC [2013/21]C07D213/64
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:N-SULFONYLBENZAMIDE ALS INHIBITOREN VON SPANNUNGSABHÄNGIGEN NATRIUMKANÄLEN[2013/21]
English:N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS[2013/21]
French:N-SULFONYLBENZAMIDES COMME INHIBITEURS DES CANAUX SODIQUES VOLTAGE-DÉPENDAN[2014/31]
Former [2013/21]N-SULFONYLBENZAMIDES COMME INHIBITEURS DES CANAUX SODIQUES VOLTAGE-DÉPENDANTS
Entry into regional phase12.02.2013National basic fee paid 
12.02.2013Designation fee(s) paid 
12.02.2013Examination fee paid 
Examination procedure16.01.2013Amendment by applicant (claims and/or description)
12.02.2013Examination requested  [2013/21]
26.11.2013Despatch of a communication from the examining division (Time limit: M06)
09.04.2014Reply to a communication from the examining division
14.07.2014Communication of intention to grant the patent
16.10.2014Fee for grant paid
16.10.2014Fee for publishing/printing paid
16.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.11.2013
Opposition(s)27.08.2015No opposition filed within time limit [2015/45]
Fees paidRenewal fee
31.07.2013Renewal fee patent year 03
31.07.2014Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.07.2011
AL26.11.2014
AT26.11.2014
BE26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MK26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
[2018/46]
Former [2018/31]HU06.07.2011
AT26.11.2014
BE26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MK26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
Former [2017/46]HU06.07.2011
AT26.11.2014
BE26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
Former [2017/39]HU06.07.2011
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
Former [2017/22]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
Former [2016/22]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
CH31.07.2015
LI31.07.2015
Former [2016/15]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
LU06.07.2015
Former [2016/13]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2016/12]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/37]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/36]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/35]AT26.11.2014
CY26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/26]AT26.11.2014
CY26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/25]AT26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/24]FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/23]FI26.11.2014
LT26.11.2014
NL26.11.2014
NO26.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/22]LT26.11.2014
NO26.02.2015
PT26.03.2015
Former [2015/21]LT26.11.2014
NO26.02.2015
Former [2015/20]LT26.11.2014
Cited inInternational search[A]WO2008025539  (PHENEX PHARMACEUTICALS AG [DE], et al) [A] 1-21* example 4; claim - *;
 [A]WO2008118758  (ICAGEN INC [US], et al) [A] 1-21 * example -; claim - *
by applicantWO9111172
 WO9402518
 WO9855148
 WO0035298
 US6106864
 WO2005013914
 WO2008047229
 WO2008118758
 WO2008135826
 WO2009012242
    - HUBNER CA, JENTSCH TJ, HUM. MOL. GENET., (2002), vol. 11, no. 20, pages 2435 - 45
    - YOGEESWARI ET AL., CURR. DRUG TARGETS, (2004), vol. 5, no. 7, pages 589 - 602
    - NOBLE D., PROC. NATL. ACAD. SCI. USA, (2002), vol. 99, no. 9, pages 5755 - 6
    - CANNON, SC, KIDNEY INT., (2000), vol. 57, no. 3, pages 772 - 9
    - WOOD, JN ET AL., J. NEUROBIOL., (2004), vol. 61, no. 1, pages 55 - 71
    - TOLEDO-ARAL ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, no. 4, pages 1527 - 1532
    - NASSAR ET AL., PROC NATL ACAD SCI USA, (2004), vol. 101, no. 34, pages 12706 - 11
    - KRETSCHMER ET AL., ACTA. NEUROCHIR. (WIEN, (2002), vol. 144, no. 8, pages 803 - 10
    - YANG ET AL., J. MED. GENET., (2004), vol. 41, no. 3, pages 171 - 4
    - WAXMAN, SG, NEUROLOGY, (20061207), vol. 69, no. 6, pages 505 - 7
    - LEGROUX-CREPEL ET AL., ANN. DERMATOL VENEREOL., vol. 130, pages 429 - 433
    - FERTLEMAN ET AL., NEURON, (2006), vol. 52, no. 5, pages 767 - 74
    - NATURE, (2006), vol. 444, no. 7121, pages 894 - 8
    - GOLDBERG ET AL., CLIN GENET., (2007), vol. 71, no. 4, pages 311 - 9
    - AHMAD ET AL., HUM MOL GENET., (200701), vol. 16, no. 17, pages 2114 - 21
    - O. ALMARSSON, M. J. ZAWOROTKO, CHEM COMMUN, (2004), vol. 17
    - HALEBLIAN, J PHARM SCI, (197508), vol. 64, no. 8, pages 1269 - 1288
    - "Pro-drugs as Novel Delivery Systems", T HIGUCHI, W STELLA, ACS Symposium Series, vol. 14
    - LIANG, CHEN, EXPERT OPINION IN THERAPEUTIC PATENTS, (2001), vol. 11, no. 6, pages 981 - 986
    - H. LIEBERMAN, L. LACHMAN, Pharmaceutical Dosage Forms: Tablets, MARCEL DEKKER, (1980), vol. 1
    - VERMA ET AL., PHARMACEUTICAL TECHNOLOGY ON-LINE, (2001), vol. 25, no. 2, pages 1 - 14
    - FINNIN, MORGAN, J PHARM SCI, (199910), vol. 88, no. 10, pages 955 - 958
    - MILLAN, PROG. NEUROBIOL., (1999), vol. 57, pages 1 - 164
    - WOOLF, SALTER, SCIENCE, (2000), vol. 288, pages 1765 - 1768
    - MEYER ET AL., Textbook of Pain, (1994), pages 13 - 44
    - WOOLF, MANNION, LANCET, (1999), vol. 353, pages 1959 - 1964
    - WOOLF, DECOSTERD, PAIN SUPP., (1999), vol. 6, pages S141 - S147
    - GRENNAN, JAYSON, Textbook of Pain, (1994), pages 397 - 407
    - HOUGE, MERSFELDER, ANN PHARMACOTHER., (2002), vol. 36, pages 679 - 686
    - MCCARTHY ET AL., Textbook of Pain, (1994), pages 387 - 395
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.